Pacific Biosciences of California PACB Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$8.28M+98.1% | -$40.37M— | -$38M+37.4% | -$41.93M+75.8% | -$426.08M-445% | ||
| $2.2M-57.1% | $2.74M-3.7% | $2.46M-41.3% | $2.66M-24.0% | $5.13M+58.4% | ||
| $4.46M-51.5% | $9.59M-40.2% | $10.98M-39.8% | $11.9M-30.9% | $9.2M-52.9% | ||
| $0+100% | —— | —— | —— | -$546K— | ||
| $0-100% | $0— | $0— | $0-100% | $15M— | ||
| -$6.1M-248% | $4.83M+360% | —— | $612K— | $4.12M+165% | ||
| $3.21M+26.3% | —— | $1.06M— | $1.33M-74.0% | $2.54M-78.2% | ||
| -$4.32M-183% | $1.72M-52.6% | $1.27M+123% | $1.02M— | -$1.53M-123% | ||
| $314K+1.0% | $4.55M— | $1.01M+130% | -$2.72M— | $311K+101% | ||
| $2.29M+167% | -$717K— | -$988K— | -$3.38M-566% | -$3.43M-12.3% | ||
| $5.13M+119% | —— | -$1.59M+73.4% | -$2.98M— | $2.35M+146% | ||
| -$225K+68.7% | -$232K-114% | -$397K-32.3% | -$340K-13.7% | -$719K-78.4% | ||
| $19K-98.6% | —— | —— | —— | $1.33M-16.8% | ||
| $1.02M-99.7% | $1.02M-85.1% | $1.02M-85.1% | $1.02M-85.1% | $366.39M+5,246% | ||
| $849K-32.5% | $894K-28.7% | $921K-81.8% | $904K-77.0% | $1.26M-34.5% | ||
| $1.43M+188% | $1.38M+152% | $1.07M+124% | -$112K+95.3% | -$1.62M+31.9% | ||
| $0+100% | $0+100% | $0-100% | $0— | -$18.7M-26,614% | ||
| -$44.69M-1.4% | -$19.07M+37.8% | -$18.71M+58.9% | -$29.38M+45.9% | -$44.06M+41.8% | ||
| $3.04M+119% | $861K-46.8% | $0— | $550K-62.8% | $1.39M-64.2% | ||
| $52.45M-15.2% | $33.09M-58.9% | $65.83M-42.6% | $56.17M-49.7% | $61.82M-67.8% | ||
| $48.25M-57.5% | $0-100% | -$195.45M— | $82.01M-56.8% | $113.44M-29.8% | ||
| $50M— | —— | —— | —— | $0— | ||
| $5M0.0% | —— | —— | —— | $5M— | ||
| $35.86M-20.7% | $26.03M-55.3% | $18.9M-18.0% | $25.28M-67.1% | $45.23M+233% | ||
| $1.44M-26.6% | -$3.43M— | $1.47M— | $0— | $1.96M— | ||
| $1.44M-26.6% | —— | $1.47M+80.9% | —— | $1.96M-70.1% | ||
| -$7.4M-336% | $6.96M+131% | $1.66M+108% | -$4.09M— | $3.14M+103% | ||
| —— | $2.07M-44.2% | $2.07M-44.2% | $2.07M-44.2% | $2.07M-44.2% | ||
| $1.02M-99.7% | $1.02M-85.1% | $1.02M-85.1% | $1.02M-85.1% | $366.39M+5,246% | ||
| $0+100% | $0+100% | $0-100% | $0— | -$18.7M-26,614% | ||
| $2.2M-57.1% | $2.74M-3.7% | $2.46M-41.3% | $2.66M-24.0% | $5.13M+58.4% | ||
| $48.1M— | —— | —— | —— | $0— | ||
| —— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| $1.43M+188% | $1.38M+152% | $1.07M+124% | -$112K+95.3% | -$1.62M+31.9% | ||
| $2.29M+167% | -$717K— | -$988K— | -$3.38M-566% | -$3.43M-12.3% | ||
| $54K-99.3% | $0-100% | $1.23M— | $883K-77.5% | $7.66M+255,200% | ||
| $295K-82.7% | $460K-80.7% | $923K-70.1% | $1.28M-64.0% | $1.71M-57.7% | ||
| $849K-32.5% | $894K-28.7% | $921K-81.8% | $904K-77.0% | $1.26M-34.5% | ||
| -$225K+68.7% | -$232K-114% | -$397K-32.3% | -$340K-13.7% | -$719K-78.4% | ||
| $1.9M— | —— | —— | —— | $0— | ||
| $5M0.0% | —— | —— | —— | $5M— | ||
| $48.25M-57.5% | $59.98M-47.2% | $84.64M-34.3% | $82.01M-56.8% | $113.44M-29.8% | ||
| $50M— | —— | —— | —— | $0— | ||
| —— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| $1.44M-26.6% | —— | $1.47M+80.9% | —— | $1.96M-71.6% | ||
| $19K-98.6% | —— | —— | —— | $1.33M-16.8% | ||
| $1.43M+188% | $1.38M+152% | $1.07M+124% | -$112K+95.3% | -$1.62M+31.9% | ||
| —— | $0— | $0— | $0— | $0— | ||
| $0-100% | $25K— | —— | —— | $29.58M— | ||
| -$47.73M-5.0% | -$19.93M+38.2% | -$18.62M+58.3% | -$29.93M+46.3% | -$45.45M+42.9% | ||
| -$47.73M-5.0% | -$19.93M+38.2% | -$18.62M+58.3% | -$29.93M+46.3% | -$45.45M+42.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Pacific Biosciences of California generate?
- Pacific Biosciences of California (PACB) generated -$111.8M in operating cash flow over the trailing twelve months.
- What is Pacific Biosciences of California's free cash flow?
- After $4.5M of capital expenditures, Pacific Biosciences of California's free cash flow was -$116.2M over the trailing twelve months, up 34.8% year over year.
- Where does Pacific Biosciences of California's cash flow data come from?
- Every line is extracted from Pacific Biosciences of California's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
